| Structure | Chemical Name | CAS | MF |
|
(5R,6R)-6-(Thymidin-α-yl)-5,6-dihydrothymidine
|
|
|
|
|
(5R)-5-[[(4S)-4-Isopropyl-2-thioxothiazolidin-3-yl]carbonylmethyl]-4-phenylfuran-2(5H)-one
|
|
|
|
(1R,2S)-2-(ISOPROPYLAMINO)-1,2-DIPHENYLETHANOL
|
71653-81-1
|
C17H21NO
|
|
(R*,S*)-4-[isopropylthio]-alpha-[1-(octylamino)ethyl]benzyl alcohol hydrochloride
|
54767-71-4
|
C20H36ClNOS
|
|
(3R,6S)-6-Isopropyl-3-methyl-5-phenyl-3,6-dihydro-2H-1,4-oxazin-2-one
|
223244-09-5
|
|
|
|
(1R,3S)-ISOMALATHION
|
|
|
|
(+)-Bicuculline
|
485-49-4
|
C20H17NO6
|
|
(1R,2S)-2-(ISOPROPYLAMINO)-1,2-DIPHENYLETHANOL
|
222555-57-9
|
C17H21NO
|
|
[R-(R*,S*)]-3-tert-Butylcarbamoyl-4-oxiranylmethyl-piperazine-1-carboxylic acid tert-butyl ester
|
158380-45-1
|
C17H31N3O4
|
|
|
R/S-4-ISOPROPYL-2-OXAZOLIDINONE
|
|
|
|
(3R,4S)-4,5-ISOPROPYLIDENE PENT-2-EN-3-OL
|
18524-19-1
|
C8H14O3
|
|
(R,S)-4-ISOBUTYLOXAZOLIDINE-2,5-DIONE
|
26334-33-8
|
C7H11NO3
|
|
(3R,4S)-4,5-ISOPROPYLIDENE-PENT-2-YN-3-OL
|
4688-38-4
|
C8H12O3
|
|
(2RS)-2-(4-ISOBUTYRYLPHENYL)PROPANOIC ACID
|
65813-55-0
|
C13H16O3
|
|
|
(1R,2R,6S,7S)-9-(Phenylthio)tricyclo[5.2.1.02,6]deca-3,8-diene
|
|
|
|
|
(1R,2R,6S,7S)-9-(α-Phenyl-α-hydroxybenzyl)tricyclo[5.2.1.02,6]deca-3,8-diene
|
|
|
|
|
(1R,2R,6S,7S)-8-(Phenylthio)tricyclo[5.2.1.02,6]deca-3,8-diene
|
|
|
|
|
(1R,2R,6S,7S)-8-(α-Phenyl-α-hydroxybenzyl)tricyclo[5.2.1.02,6]deca-3,8-diene
|
|
|
|
|
(2R)-2α-[(1R,2S,3S,4R)-1,2,3,4,5-Pentaacetoxypentyl]-3-acetyl-4β-methoxycarbonyl-5,5-dimethylthiazolidine 1-oxide
|
|
|
|
|
(20R,22R,24S,25S,28R)-2β,3β,5,14,20,22,28-Heptahydroxy-6-oxo-5β-stigmasta-7-ene-27-oic acid γ-lactone
|
22799-11-7
|
|
|
|
(1R,5R,6S,7S,8R)-6-Benzyloxymethyl-7-hydroxy-8-iodo-2-oxabicyclo[3.3.0]octan-3-one
|
|
|
|
|
(1R,5R,6S,7S,8R)-6-Benzyloxymethyl-8-iodo-7-(tetrahydro-2H-pyran-2-yloxy)-2-oxabicyclo[3.3.0]octan-3-one
|
|
|
|
|
(2R,2'R,3S,3'S,4R,4'R)-2,2'-Bis(3,4-dihydroxyphenyl)-4,6'-bichroman-3,3',4',7,7'-pentol
|
|
|
|
(3R,5R,6S,7S,9R,11E,13R,14R)-3,5,7,9,13-Pentamethyl-6-hydroxy-14-ethyl-1-oxa-11-cyclotetradecene-2,4,10-trione
|
32885-75-9
|
|
|
|
(1R,5R,6S,7S,9R)-5,6-Epoxy-6-[[(Z)-2-methyl-2-butenoyloxy]methyl]-10,10-dimethyl-2-methylenebicyclo[7.2.0]undecan-7β-ol
|
|
|
|
(3R,5R,6S,7S,9R,11E,13S,14R)-3,5,7,9,13-Pentamethyl-6,13-dihydroxy-14-ethyl-1-oxacyclotetradeca-11-ene-2,4,10-trione
|
51724-55-1
|
|
|
|
(1R,5R,6S,7S,8R)-7-Hydroxy-8-iodo-6-methoxymethyl-2-oxabicyclo[3.3.0]octan-3-one
|
|
|
|
|
[(2R,2'R,3S,3'S,4R)-2,2'-Bis(3,4-dihydroxyphenyl)-3',5,5',7,7'-pentahydroxy-4,8'-bichroman-3-yl]6-deoxy-α-L-mannopyranoside
|
|
|
|
(2R,3R,4S,5S,6R)-4-Amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxy-cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
|
34493-98-6
|
C18H37N5O8
|
|
Dibekacin sulfate
|
58580-55-5
|
C18H37N5O11S
|
|
|
(3R,5R)-7-[(1S,2S,6R, 8S,8aR)-8-[(2,2-dimethyl butanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid(hydroxy acid)
|
|
|
|
(2R,3R,4S,5S,6R)-6-methyloxane-2,3,4,5-tetrol
|
28161-52-6
|
C6H12O5
|
|
2-[[(5R,6R,7S,9S,11R,18R,19S)-19-amino-6-(3,4-dicarboxybutanoyloxy)-11 ,18-dihydroxy-5,9-dimethyl-icosan-7-yl]oxycarbonylmethyl]butanedioic a cid
|
136379-59-4
|
C34H59NO14
|
|
2-[[(4R)-4-[(3R,5S,7S,10R,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4, 5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren -17-yl]pentanoyl]-methyl-amino]acetic acid
|
88446-87-1
|
C27H45NO5
|
|
|
(2R,3R,10S,12S,13R,14R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methyl-heptan- 2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-c yclopenta[a]phenanthrene-2,3,12-triol
|
64971-22-8
|
C30H52O5
|
|
(2R,3R)/(2S,3S)-RACEMIC FMOC-BETA-HYDROXY-PHENYLALANINE
|
|
C24H21NO5
|
|
(2R,3R)/(2S,3S)-RACEMIC BOC-BETA-METHYL-PHENYLALANINE
|
|
C15H21NO4
|
|
|
(2R: 3R)/(2S: 3S)-RACEMIC-BOC--METHYL-PHENYLALANINE
|
|
C15H21NO4
|
|
(2R,3R)/(2S,3S)-RACEMIC FMOC-BETA-METHYL-PHENYLALANINE
|
321524-79-2
|
C25H23NO4
|
|
(2R,3R)/(2S,3S)-RACEMIC BOC-BETA-HYDROXY-PHENYLALANINE
|
93847-77-9
|
C14H19NO5
|
|
2-[[(4R)-4-[(3R,5S,7S,10R,13R,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
|
64480-66-6
|
C26H43NO5
|
|
|
(2R,2'R,3S,3'S,4S,4'R)-3,3',4,4'-Tetrahydro-2,2'-bis(3,4-dihydroxyphenyl)-4,6'-bi[2H-1-benzopyran]-3,3',4',7,7'-pentol
|
20254-30-2
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-en-18-al
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-hydroxybeyer-15-en-18-oic acid methyl ester
|
|
|
|
|
(1R,2R,3S,6S,7S)-Tricyclo[5.2.1.02,6]decane-3β-ol
|
|
|
|
|
(1R,2R,4S,5S)-7β-[[[(S)-2-Hydroxy-1-phenylethyl]carbonyl]oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonane 9-oxide
|
|
|
|
Ertapenem
|
153832-46-3
|
C22H25N3O7S
|
|
(3R,5R,8S,9S,10S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-3,17-dihydr oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopen ta[a]phenanthren-11-one
|
667-66-3
|
C21H34O5
|
|
(3R,5R,8S,9S,10S,11S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12 ,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,11,17-triol
|
20685-55-6
|
C19H32O3
|
|
|
(2R,3R,4S,5S,6S)-2-[(1R)-1,2-dihydroxyethyl]-6-[(2R,3S,4S,5S,6R)-6-[(1 R)-1,2-dihydroxyethyl]-2,5-dihydroxy-2-methyl-4-[(2R,3R,4S,5R,6R)-3,4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-3-yl]oxy-oxane-3,4,5- triol
|
131289-51-5
|
C21H38O18
|
|
(2R,3R,4S,5S,6S)-2-[(2R,3S,4R,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl) oxolan-2-yl]oxy-6-(sulfanylmethyl)oxane-3,4,5-triol
|
92596-11-7
|
C12H22O10S
|
|
|
（1R，2R，4S，5S，7s)-7-[2-hydroxy-2,2-di(2-thienyl)acetoxy]-9-methyl-3-oxatricyclo[3.3.1.02,4]nonane
|
|
|
|
|
(8R,9R,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-(2-methylprop-2-enyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
|
2824-50-2
|
C23H34O2
|
|
(8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one
|
1225-01-0
|
C18H28O2
|
|
|
(3R,4R,6S,7S,11S,12R)-7,11-Dibromo-6-chloro-7,10,10-trimethyl-1-oxadispiro[2.0.5.4]tridecan-12-ol
|
|
|
|
|
(2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-phenoxy-1,3'-biazetidine
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyera-15-ene-18-oic acid
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyer-15-en-18-oic acid methyl ester
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-18-hydroxybeyer-15-ene
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-ene-3α,18-diol
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-en-18-oic acid
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α,19-(isopropylidenebisoxy)beyer-15-ene
|
|
|
|
|
(1R,5R,6S,7S,8S)-7-Acetoxy-8-iodo-6-(methoxymethyl)-2-oxabicyclo[3.3.0]octan-3-one
|
|
|
|
|
(2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-hydroxy-1,3'-biazetidine
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-hydroxybeyer-15-en-18-oic acid
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carboxylic acid ethyl ester
|
|
|
|
|
(R)-2-[[(2R,4S,5S)-5-(tert-Butoxycarbonylamino)-2-benzyl-4-hydroxy-6-phenylhexanoyl]amino]-4-methylpentanamide
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carboxylic acid ethyl ester
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carbaldehyde
|
|
|
|
|
(1R,3R,5S,7S)-1,3,5,7-Tetramethyl-2-thiatricyclo[3.3.1.13,7]decane-4,6,8-trione
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carbaldehyde
|
|
|
|
(1R,2R,3S,5S)-3-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-2-HEXYL-5-UNDECYL-CYCLOPENTANOL
|
|
C28H58O2Si
|
|
[1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate
|
67843-79-2
|
C17H26O2
|
|
[1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undecen-5-yl formate
|
85136-29-4
|
C16H24O2
|
|
[(2R,3R,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxyphosphonic acid
|
3672-15-9
|
C6H13O9P
|
|
(1R,3R,4S,6S)-4-TERT-BUTOXYCARBONYLAMINO-4,7,7-TRIMETHYL-BICYCLO[4.1.0]HEPTANE-3-CARBOXYLIC ACID
|
654680-62-3
|
C16H27NO4
|
|
|
Rsk1, active (MAPKAP K1a, Kinase 1a)
|
|
|
|
|
Rsk3, active, Recombinant, Human (Ribosomal S6 Kinase 3)
|
|
|
|
|
Rsk1, active, Recombinant, Human (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
|
|
|
|
Rsk2, active, Recombinant, Human (Ribosomal S6 Kinase 2, MAPKAP K1b, Kinase1b)
|
|
|
|
|
Rsk1, active, Recombinant, Rat (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
|
|
|
|
(2R,4'R,8'S)-5,7,8-Trimethyltocol
|
|
|
|
|
(2R,3R,4S)-2,3,4-Trimethoxy-5-hexenal
|
|
|
|
|
(1R,5R,7S)-Tricyclo[5.4.0.01,5]undecane-8-one
|
|
|
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,5,7-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
|
|
(2R,3R,4S)-2-Triphenylmethoxy-4-methyl-5-hexen-3-ol
|
|
|
|
|
(1R,3R,4S)-3-(Triethylsiloxy)-p-menthane
|
|
|
|
|
3-[(1R,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2β-yl]cyclohexanol
|
|
|
|
|
(22R,23R,24S)-3β,22,23-Trihydroxy-5α-ergostan-6-one
|
92751-21-8
|
|
|
|
(22R,23R,24S)-3α,22,23-Trihydroxy-5α-ergostan-6-one
|
87734-68-7
|
|
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,8-dimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
|
|
(2R,3R,4S)-2,3,4-trihydroxy-4-(2-phenyl-2H-1,2,3-triazol-4-yl)butyl 4-methylbenzenesulfonate
|
|
|
|
(1R,4R,10S)-4,12,12-TRIMETHYL-9-METHYLENE-5-OXA-TRICYCLO[8.2.0.0(4,6)]DODECANE
|
|
C15H24O
|
|
|
(1R,2R)-1-Styryl-2-methyl-2-vinyl-1,3-propanediol
|
|
|
|
|
rSIVp55
|
|
|
|
|
RSK-B protein
|
|
|
|
|
rRTNC
|
|
|
|
|
RT1Ac (MHC Class I)
|
|
|
|
|
rrTNF-a
|
|
|